Skip to main content
. Author manuscript; available in PMC: 2022 May 3.
Published in final edited form as: Clin Cancer Res. 2022 May 2;28(9):1863–1870. doi: 10.1158/1078-0432.CCR-21-3018

Table 2:

Characteristics of the validation cohort.

Characteristics No. (%)
CRC cases 816
RNF43 mutation status
Mutated 65 (7.97)
Wildtype 751 (92.03)
Comutations in APC, KRAS, BRAF and 57 (88)
NRAS
No comutation in the respective genes 8 (12)
Microsatellite status
MSI-H/dMMR (%) 7 (11)
MSS/pMMR (%) 42 (64)
Not reported (%) 16 (25)